Premium
Anxiety in youth with asthma: A meta‐analysis
Author(s) -
Dudeney Joanne,
Sharpe Louise,
Jaffe Adam,
Jones Emma B.,
Hunt Caroline
Publication year - 2017
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.23689
Subject(s) - anxiety , asthma , medicine , psycinfo , cinahl , psychiatry , anxiety disorder , clinical psychology , medline , prevalence , epidemiology , psychological intervention , political science , law
Abstract OBJECTIVES Anxiety often presents comorbidly with asthma in youth under 18; however, prevalence rates are unclear. The aim of this review was to provide an up‐to‐date analysis of the literature investigating the prevalence of anxiety disorders, and comparisons of anxiety disorders and symptomatology in youth with asthma, compared to those without. METHODS A systematic search was conducted using the databases PsycINFO, MEDLINE, EMBASE, and CINAHL. RESULTS The search process produced 15 studies ( n = 7443) reporting data on youth with asthma and anxiety disorders, 11 studies ( n = 10 332) reporting data on youth with and without asthma and anxiety disorders, and 28 studies ( n = 5848) reporting data on youth with and without asthma and anxiety symptomatology. Youth with asthma had an anxiety disorder prevalence rate of 22.7%. Youth with asthma also had a greater number of anxiety disorders, compared to those without asthma ( d = 0.37, 95%CI: 0.24‐0.50, P < 0.001), and higher levels of anxiety symptomatology than youth without asthma ( d = 0.29, 95%CI: 0.19‐0.39, P < 0.001). CONCLUSIONS Youth with asthma display a prevalence rate for anxiety disorders that is more than three times higher than the prevalence in healthy youth. For the specific anxiety disorders investigated, elevated prevalence rates for youth with asthma were also found. Future research needs to focus on the factors that mediate or predict the development and maintenance of anxiety in youth with asthma and the development of clinically efficacious treatments.